nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminohippurate—ABCC1—Vemurafenib—skin cancer	0.216	0.225	CbGbCtD
Aminohippurate—ABCC1—Dactinomycin—skin cancer	0.143	0.149	CbGbCtD
Aminohippurate—SLC22A5—Dactinomycin—skin cancer	0.136	0.142	CbGbCtD
Aminohippurate—SLC22A7—Fluorouracil—skin cancer	0.124	0.129	CbGbCtD
Aminohippurate—SLC22A7—Docetaxel—skin cancer	0.0943	0.0982	CbGbCtD
Aminohippurate—ABCC1—Docetaxel—skin cancer	0.0741	0.0771	CbGbCtD
Aminohippurate—ABCB1—Vismodegib—skin cancer	0.0659	0.0686	CbGbCtD
Aminohippurate—ABCC2—Docetaxel—skin cancer	0.0548	0.0571	CbGbCtD
Aminohippurate—ABCB1—Dactinomycin—skin cancer	0.0346	0.036	CbGbCtD
Aminohippurate—ABCB1—Docetaxel—skin cancer	0.0179	0.0186	CbGbCtD
Aminohippurate—Procaine—SCN10A—skin cancer	0.0029	0.277	CrCbGaD
Aminohippurate—Feeling hot—Imiquimod—skin cancer	0.00254	0.0902	CcSEcCtD
Aminohippurate—Tingling sensation—Imiquimod—skin cancer	0.00248	0.088	CcSEcCtD
Aminohippurate—Benzocaine—SCN10A—skin cancer	0.00231	0.22	CrCbGaD
Aminohippurate—Muscle spasms—Vismodegib—skin cancer	0.00159	0.0565	CcSEcCtD
Aminohippurate—Procainamide—SCN10A—skin cancer	0.0015	0.143	CrCbGaD
Aminohippurate—Tingling sensation—Fluorouracil—skin cancer	0.00137	0.0486	CcSEcCtD
Aminohippurate—Bromfenac—PTGS2—skin cancer	0.00111	0.106	CrCbGaD
Aminohippurate—Balsalazide—PTGS2—skin cancer	0.00104	0.0989	CrCbGaD
Aminohippurate—Flushing—Imiquimod—skin cancer	0.00093	0.033	CcSEcCtD
Aminohippurate—Fenbufen—PTGS2—skin cancer	0.000862	0.0823	CrCbGaD
Aminohippurate—Vomiting—Vismodegib—skin cancer	0.000859	0.0305	CcSEcCtD
Aminohippurate—Anaphylactic shock—Vemurafenib—skin cancer	0.000835	0.0296	CcSEcCtD
Aminohippurate—Nausea—Vismodegib—skin cancer	0.000803	0.0285	CcSEcCtD
Aminohippurate—Angioedema—Imiquimod—skin cancer	0.000797	0.0283	CcSEcCtD
Aminohippurate—Tolmetin—PTGS2—skin cancer	0.000749	0.0715	CrCbGaD
Aminohippurate—Flushing—Bleomycin—skin cancer	0.000661	0.0234	CcSEcCtD
Aminohippurate—Paraesthesia—Imiquimod—skin cancer	0.000639	0.0227	CcSEcCtD
Aminohippurate—Flushing—Dactinomycin—skin cancer	0.000616	0.0219	CcSEcCtD
Aminohippurate—Hypersensitivity—Vemurafenib—skin cancer	0.000615	0.0218	CcSEcCtD
Aminohippurate—Urticaria—Imiquimod—skin cancer	0.000566	0.0201	CcSEcCtD
Aminohippurate—Flushing—Temozolomide—skin cancer	0.000557	0.0198	CcSEcCtD
Aminohippurate—Vomiting—Vemurafenib—skin cancer	0.000531	0.0188	CcSEcCtD
Aminohippurate—Hypersensitivity—Imiquimod—skin cancer	0.000525	0.0186	CcSEcCtD
Aminohippurate—Cramp muscle—Docetaxel—skin cancer	0.00052	0.0184	CcSEcCtD
Aminohippurate—Anaphylactic shock—Bleomycin—skin cancer	0.000506	0.0179	CcSEcCtD
Aminohippurate—Nausea—Vemurafenib—skin cancer	0.000496	0.0176	CcSEcCtD
Aminohippurate—Angioedema—Temozolomide—skin cancer	0.000478	0.0169	CcSEcCtD
Aminohippurate—Paraesthesia—Bleomycin—skin cancer	0.000454	0.0161	CcSEcCtD
Aminohippurate—Vomiting—Imiquimod—skin cancer	0.000453	0.0161	CcSEcCtD
Aminohippurate—Anaphylactic shock—Temozolomide—skin cancer	0.000427	0.0151	CcSEcCtD
Aminohippurate—Nausea—Imiquimod—skin cancer	0.000423	0.015	CcSEcCtD
Aminohippurate—Urticaria—Bleomycin—skin cancer	0.000402	0.0142	CcSEcCtD
Aminohippurate—Anaphylactic shock—Fluorouracil—skin cancer	0.000393	0.0139	CcSEcCtD
Aminohippurate—Paraesthesia—Temozolomide—skin cancer	0.000383	0.0136	CcSEcCtD
Aminohippurate—Hypersensitivity—Bleomycin—skin cancer	0.000373	0.0132	CcSEcCtD
Aminohippurate—Flushing—Docetaxel—skin cancer	0.000371	0.0131	CcSEcCtD
Aminohippurate—Paraesthesia—Fluorouracil—skin cancer	0.000353	0.0125	CcSEcCtD
Aminohippurate—Hypersensitivity—Dactinomycin—skin cancer	0.000348	0.0123	CcSEcCtD
Aminohippurate—Urticaria—Temozolomide—skin cancer	0.000339	0.012	CcSEcCtD
Aminohippurate—Muscle spasms—Docetaxel—skin cancer	0.000334	0.0119	CcSEcCtD
Aminohippurate—Vomiting—Bleomycin—skin cancer	0.000322	0.0114	CcSEcCtD
Aminohippurate—Hypersensitivity—Temozolomide—skin cancer	0.000314	0.0111	CcSEcCtD
Aminohippurate—Urticaria—Fluorouracil—skin cancer	0.000312	0.0111	CcSEcCtD
Aminohippurate—Nausea—Bleomycin—skin cancer	0.0003	0.0107	CcSEcCtD
Aminohippurate—Vomiting—Dactinomycin—skin cancer	0.0003	0.0106	CcSEcCtD
Aminohippurate—Hypersensitivity—Fluorouracil—skin cancer	0.00029	0.0103	CcSEcCtD
Aminohippurate—Anaphylactic shock—Docetaxel—skin cancer	0.000284	0.0101	CcSEcCtD
Aminohippurate—Nausea—Dactinomycin—skin cancer	0.00028	0.00994	CcSEcCtD
Aminohippurate—Vomiting—Temozolomide—skin cancer	0.000271	0.00962	CcSEcCtD
Aminohippurate—Paraesthesia—Docetaxel—skin cancer	0.000255	0.00904	CcSEcCtD
Aminohippurate—Nausea—Temozolomide—skin cancer	0.000253	0.00899	CcSEcCtD
Aminohippurate—Vomiting—Fluorouracil—skin cancer	0.00025	0.00886	CcSEcCtD
Aminohippurate—Nausea—Fluorouracil—skin cancer	0.000234	0.00828	CcSEcCtD
Aminohippurate—Hypersensitivity—Docetaxel—skin cancer	0.000209	0.00741	CcSEcCtD
Aminohippurate—Vomiting—Docetaxel—skin cancer	0.00018	0.0064	CcSEcCtD
Aminohippurate—Nausea—Docetaxel—skin cancer	0.000169	0.00598	CcSEcCtD
Aminohippurate—SLCO3A1—nipple—skin cancer	3.31e-05	0.085	CbGeAlD
Aminohippurate—ABCC1—hair follicle—skin cancer	2.61e-05	0.0671	CbGeAlD
Aminohippurate—SLC22A4—neck—skin cancer	2.33e-05	0.0598	CbGeAlD
Aminohippurate—SLCO3A1—mammalian vulva—skin cancer	1.93e-05	0.0496	CbGeAlD
Aminohippurate—SLC16A1—epithelium—skin cancer	1.84e-05	0.0472	CbGeAlD
Aminohippurate—SLC22A11—female reproductive system—skin cancer	1.83e-05	0.0469	CbGeAlD
Aminohippurate—ABCC1—nipple—skin cancer	1.77e-05	0.0455	CbGeAlD
Aminohippurate—SLCO3A1—female reproductive system—skin cancer	1.66e-05	0.0425	CbGeAlD
Aminohippurate—SLC22A5—nipple—skin cancer	1.56e-05	0.04	CbGeAlD
Aminohippurate—SLCO3A1—head—skin cancer	1.38e-05	0.0355	CbGeAlD
Aminohippurate—SLC16A1—female reproductive system—skin cancer	1.36e-05	0.035	CbGeAlD
Aminohippurate—SLCO1B1—female reproductive system—skin cancer	1.33e-05	0.0341	CbGeAlD
Aminohippurate—SLC22A4—female reproductive system—skin cancer	1.18e-05	0.0302	CbGeAlD
Aminohippurate—SLC16A1—head—skin cancer	1.14e-05	0.0293	CbGeAlD
Aminohippurate—ABCC1—mammalian vulva—skin cancer	1.04e-05	0.0266	CbGeAlD
Aminohippurate—ABCC2—female reproductive system—skin cancer	1.01e-05	0.0258	CbGeAlD
Aminohippurate—ABCB1—blood vessel—skin cancer	1e-05	0.0257	CbGeAlD
Aminohippurate—SLC22A5—skin of body—skin cancer	9.99e-06	0.0256	CbGeAlD
Aminohippurate—SLCO3A1—lymph node—skin cancer	9.69e-06	0.0249	CbGeAlD
Aminohippurate—SLC22A1—head—skin cancer	9.38e-06	0.0241	CbGeAlD
Aminohippurate—SLCO1A2—head—skin cancer	9.03e-06	0.0232	CbGeAlD
Aminohippurate—SLC22A8—head—skin cancer	8.62e-06	0.0221	CbGeAlD
Aminohippurate—SLC16A1—lymph node—skin cancer	7.98e-06	0.0205	CbGeAlD
Aminohippurate—SLC22A5—female reproductive system—skin cancer	7.8e-06	0.02	CbGeAlD
Aminohippurate—SLC22A4—lymph node—skin cancer	6.89e-06	0.0177	CbGeAlD
Aminohippurate—ABCC2—lymph node—skin cancer	5.89e-06	0.0151	CbGeAlD
Aminohippurate—ABCC1—lymph node—skin cancer	5.19e-06	0.0133	CbGeAlD
Aminohippurate—ABCB1—epithelium—skin cancer	4.87e-06	0.0125	CbGeAlD
Aminohippurate—SLC22A5—lymph node—skin cancer	4.56e-06	0.0117	CbGeAlD
Aminohippurate—ABCB1—mammalian vulva—skin cancer	4.23e-06	0.0108	CbGeAlD
Aminohippurate—ABCB1—lymphoid tissue—skin cancer	3.75e-06	0.00963	CbGeAlD
Aminohippurate—ABCB1—female reproductive system—skin cancer	3.62e-06	0.00929	CbGeAlD
Aminohippurate—ABCB1—head—skin cancer	3.02e-06	0.00776	CbGeAlD
Aminohippurate—ABCB1—lymph node—skin cancer	2.12e-06	0.00544	CbGeAlD
